Transcranial Magnetic Stimulation in SUD Treatment

Transcranial Magnetic Stimulation in the Treatment of Stimulant Use Disorder

In this session, Kathleen T. Brady, MD, PhD, of the Medical University of South Carolina, will discuss the NIDA N Clinical Trials Network (CTN) study CTN-0108, “Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder,” a pilot study that aims to determine the feasibility, effectiveness, and safety for 20 sessions of repetitive transcranial magnetic stimulation (rTMS) versus sham in adults with a diagnosed methamphetamine or cocaine use disorder.

Dr. Brady, co-Principal Investigator for CTN-0108, will present the rationale for the study, including the literature supporting the use of rTMS in stimulant use disorder, as well as the study methodology and preliminary results.

Objectives:

• List 3 key research findings supporting the use of TMS in treating substance use disorders
• Describe at least 3 key elements of the methodology for a trial of TMS in treating simulant use disorders
• Identify at least 3 preliminary data points from the CTN-0108 study

Register & learn more
 

For trainings that indicate Continuing Education Units (CEUs) are available, contact the organizer and/or the Vermont Office of Professional Regulation to verify that the credits will count toward the continuing education requirements of your licensure or certification.